SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Atrion Corp. – ‘10-K’ for 12/31/20 – ‘EX-10.N’

On:  Friday, 2/26/21, at 5:51pm ET   ·   As of:  3/1/21   ·   For:  12/31/20   ·   Accession #:  1654954-21-2137   ·   File #:  1-32982

Previous ‘10-K’:  ‘10-K/A’ on 5/26/20 for 12/31/19   ·   Next:  ‘10-K’ on 2/25/22 for 12/31/21   ·   Latest:  ‘10-K’ on 2/29/24 for 12/31/23   ·   19 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/01/21  Atrion Corp.                      10-K       12/31/20   77:5.2M                                   Blueprint/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    850K 
 2: EX-4.A      Instrument Defining the Rights of Security Holders  HTML     33K 
 3: EX-10.M     Material Contract                                   HTML     37K 
 4: EX-10.N     Material Contract                                   HTML     37K 
 5: EX-10.O     Material Contract                                   HTML     38K 
 6: EX-10.Y     Material Contract                                   HTML     83K 
 7: EX-13.1     Stock Performance Graph                             HTML     25K 
 8: EX-21       Subsidiaries of Atrion Corporation                  HTML     22K 
 9: EX-23       Consent of Independent Registered Public            HTML     19K 
                Accounting Firm                                                  
10: EX-31.1     Chief Executive Officer Certification               HTML     25K 
11: EX-31.2     Chief Financial Officer Certification               HTML     24K 
12: EX-32.1     Certification Pursuant to 18 U.S.C. Section 1350,   HTML     20K 
                as Adopted Pursuant to Section 906 of the Sarbanes               
                Oxley Act of 2002                                                
13: EX-32.2     Certification Pursuant to 18 U.S.C. Section 1350,   HTML     20K 
                as Adopted Pursuant to Section 906 of the Sarbanes               
                Oxley Act of 2002                                                
20: R1          Cover                                               HTML     75K 
21: R2          Consolidated Statements of Income                   HTML     72K 
22: R3          Consolidated Balance Sheets                         HTML    110K 
23: R4          Consolidated Balance Sheets (Parenthetical)         HTML     35K 
24: R5          Consolidated Statements of Cash Flows               HTML     95K 
25: R6          Consolidated Statements of Changes in Stockholders  HTML     60K 
                Equity                                                           
26: R7          Summary of Significant Accounting Policies          HTML    101K 
27: R8          Investments                                         HTML     69K 
28: R9          Patents and Licenses                                HTML     32K 
29: R10         Line of Credit                                      HTML     24K 
30: R11         Income Taxes                                        HTML     76K 
31: R12         Stockholders' Equity                                HTML     24K 
32: R13         Income Per Share                                    HTML     40K 
33: R14         Stock-based Compensation                            HTML     65K 
34: R15         Industry Segment and Geographic Information         HTML     22K 
35: R16         Employee Retirement and Benefit Plans               HTML     25K 
36: R17         Commitment and Contingencies                        HTML     25K 
37: R18         Summary of Significant Accounting Policies          HTML    140K 
                (Policies)                                                       
38: R19         Summary of Significant Accounting Policies          HTML     92K 
                (Tables)                                                         
39: R20         Investments (Tables)                                HTML     66K 
40: R21         Patents and Licenses (Tables)                       HTML     33K 
41: R22         Income Taxes (Tables)                               HTML     80K 
42: R23         Income Per Share (Tables)                           HTML     39K 
43: R24         Stock-based Compensation (Tables)                   HTML     63K 
44: R25         Summary of Significant Accounting Policies          HTML     59K 
                (Details)                                                        
45: R26         Summary of Significant Accounting Policies          HTML     29K 
                (Details 1)                                                      
46: R27         Summary of Significant Accounting Policies          HTML     37K 
                (Details 2)                                                      
47: R28         Summary of Significant Accounting Policies          HTML     31K 
                (Details 3)                                                      
48: R29         Summary of Significant Accounting Policies          HTML     28K 
                (Details 4)                                                      
49: R30         Summary of Significant Accounting Policies          HTML     29K 
                (Details 5)                                                      
50: R31         Summary of Significant Accounting Policies          HTML     56K 
                (Details Narrative)                                              
51: R32         Investments (Details)                               HTML     40K 
52: R33         Investments (Details 1)                             HTML     38K 
53: R34         Investments (Details Narrative)                     HTML     27K 
54: R35         Patents and Licenses (Details)                      HTML     27K 
55: R36         Patents and Licenses (Details 1)                    HTML     32K 
56: R37         Patents and Licenses (Details Narrative)            HTML     23K 
57: R38         Line of Credit (Details Narrative)                  HTML     27K 
58: R39         Income Taxes (Details)                              HTML     38K 
59: R40         Income Taxes (Details 1)                            HTML     39K 
60: R41         Income Taxes (Details 2)                            HTML     43K 
61: R42         Income Taxes (Details 3)                            HTML     30K 
62: R43         Income Taxes (Details Narrative)                    HTML     27K 
63: R44         Stockholders Equity (Details Narrative)             HTML     32K 
64: R45         Income Per Share (Details)                          HTML     43K 
65: R46         Income Per Share (Details Narrative)                HTML     23K 
66: R47         Stock-based Compensation (Details)                  HTML     53K 
67: R48         Stock-based Compensation (Details 1)                HTML     35K 
68: R49         Stock-based Compensation (Details 2)                HTML     41K 
69: R50         Stock-based Compensation (Details 3)                HTML     37K 
70: R51         Stock-based Compensation (Details Narrative)        HTML     61K 
71: R52         Industry Segment and Geographic Information         HTML     21K 
                (Details Narrative)                                              
72: R53         Employee Retirement and Benefit Plans (Details      HTML     25K 
                Narrative)                                                       
73: R54         Commitment and contingencies (Details Narrative)    HTML     27K 
75: XML         IDEA XML File -- Filing Summary                      XML    125K 
19: XML         XBRL Instance -- atri_10k_htm                        XML   1.18M 
74: EXCEL       IDEA Workbook of Financial Reports                  XLSX     76K 
15: EX-101.CAL  XBRL Calculations -- atri-20201231_cal               XML    132K 
16: EX-101.DEF  XBRL Definitions -- atri-20201231_def                XML    281K 
17: EX-101.LAB  XBRL Labels -- atri-20201231_lab                     XML    801K 
18: EX-101.PRE  XBRL Presentations -- atri-20201231_pre              XML    619K 
14: EX-101.SCH  XBRL Schema -- atri-20201231                         XSD    141K 
76: JSON        XBRL Instance as JSON Data -- MetaLinks              267±   370K 
77: ZIP         XBRL Zipped Folder -- 0001654954-21-002137-xbrl      Zip    204K 


‘EX-10.N’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 

 

EXHIBIT 10n

 

FIRST AMENDED AND RESTATED RESTRICTED

 

STOCK UNIT AWARD AGREEMENT

 

THIS FIRST AMENDED AND RESTATED RESTRICTED STOCK UNIT AWARD AGREEMENT (the “Agreement”) is made and entered into as of December 29, 2020, by and between ATRION CORPORATION, a Delaware corporation (the “Company”), and DAVID A. BATTAT (“Battat”).

 

W I T N E S S E T H:

 

WHEREAS, pursuant to the Amended and Restated Atrion Corporation 2006 Equity Incentive Plan (the “Plan”), the Compensation Committee of the Board of Directors of Atrion Corporation granted an Award (as defined in the Plan) of Restricted Stock Units (“RSUs”) to Battat as of July 1, 2020; and

  

WHEREAS, the Company and Battat entered into an Award Agreement dated as of July 1, 2020 (the “Original Agreement”) setting forth the terms and conditions of such Award; and

  

WHEREAS, Plan provides that RSUs are to be settled in common stock of the Company, and the Company and Battat have agreed that such Award is to be settled in cash rather than in common stock of the Company and should be deemed to be made separate and apart from, and not pursuant to, the Plan.  

 

NOW, THEREFORE, for and in consideration of the premises, the mutual promises and covenants herein contained, and other good and valuable consideration, the receipt, adequacy and sufficiency of which are hereby acknowledged, the parties hereto do hereby agree as follows: 

 

1. AWARD OF RESTRICTED STOCK UNITS. Effective as of the date set forth in Exhibit A attached hereto (the “Date of Grant”), the Company granted to Battat an Award in the form of Restricted Stock Units (“RSUs”) entitling Battat to receive from the Company upon lapse of restrictions and vesting, without payment, one share of Common Stock (a “Share”) for each RSU set forth on said Exhibit A, and the Company and Battat entered into the Original Agreement. The parties hereby agree that (i) the RSUs shall be deemed to have been granted separate and apart from, and not pursuant to, the Plan and (ii) the Award and the RSUs shall be governed by the terms of this Agreement.

 

2. EFFECT OF PLAN. Although the RSUs are deemed to be granted separate and apart from, and not pursuant to, the Plan, capitalized term used herein and not otherwise defined shall have the meanings ascribed thereto in the Plan and are incorporated herein by reference. Battat hereby agrees that all decisions and determinations of the Board of Directors of the Corporation with respect to the matters set forth herein shall be final and binding on Battat, his beneficiaries, and any other person having or claiming an interest in the RSUs.

 

3. RESTRICTIONS. The restrictions under this Award shall lapse and the RSUs shall vest on the Vesting Dates set forth in Exhibit A or, if earlier, on a Change in Control. The RSUs as to which the restrictions shall not have lapsed and which are not vested shall be forfeited upon Battat’s Termination of Employment; provided, however, that if Battat’s Termination of Employment is because of Battat’s death, “retirement” (as defined below), Permanent Disability, termination of employment by the Company without “Just Cause” (as defined in, and in accordance with the provisions of, Battat’s Amended and Restated Change in Control Agreement with the Company) or by Battat for “Good Reason” (as defined in, and in accordance with the provisions of, Battat’s Amended and Restated Change in Control Agreement with the Company), then, notwithstanding the foregoing, the restrictions as to all such RSUs shall lapse, and all of such RSUs shall become one hundred percent (100%) vested on the date of Termination of Employment. The RSUs may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated until such restrictions lapse and the RSUs vest, except as otherwise provided in Paragraph 7 below. For purposes of this Agreement, the term “retirement” shall mean the voluntary termination of employment by Battat, provided that in connection with such termination Battat represents and warrants to the Company that he intends to not be actively engaged in the workforce after such termination.

 

 
1
 

 

4. RIGHTS PRIOR TO VESTING. On January 1, 2021, Battat shall be credited with dividend equivalents in the form of RSUs equal to the aggregate amount of dividends paid during the period beginning on the Date of Grant and ending on December 31, 2020 on the number of outstanding shares of Common Stock that equals the number of RSUs credited to Battat on each date such dividends were paid divided by the closing market price for the Common Stock on such dividend payment dates. On each Vesting Date set forth on Exhibit A, Battat shall be credited with dividend equivalents in the form of cash equal to the aggregate amount of dividends paid during the period beginning on the immediately preceding Vesting Date and ending on such Vesting Date on the number of outstanding shares of Common Stock that equals the number of RSUs credited to Battat on each date such dividends were paid; provided, however, that with respect to the first Vesting Date set forth on Exhibit A the period shall begin on January 1, 2021 and shall end on such first Vesting Date. The RSUs and cash credited to Battat as a result of dividends paid by the Company with respect to the Common Stock shall be subject to the restrictions and forfeiture provisions set forth in Paragraph 3 above. The RSUs and cash credited as dividend equivalents as a result of dividends paid by the Company with respect to the Common Stock shall be delivered or paid to Battat in accordance with Paragraph 5 below.

 

5. SETTLEMENT OF RSUs. Vested RSUs shall be settled by a cash payment for each such RSU in an amount equal to the Fair Market Value of a share of Common Stock on the day immediately preceding the Vesting Date set forth in Exhibit A, such payment to be made as soon as administratively practicable following the vesting of the applicable RSUs and, in any event, no later than March 15th of the calendar year following the year in which the applicable RSUs vest. Each such payment shall be accompanied by a payment of the cash accrued as dividend equivalents with respect to the RSUs then vested.

 

6. SECURITIES LAW RESTRICTIONS. Acceptance of this Agreement shall be deemed to constitute Battat’s acknowledgement that the RSUs shall be subject to such restrictions and conditions on any resale and on any other disposition as the Company shall deem necessary under any applicable laws or regulations or in light of any stock exchange requirements.

 

7. TRANSFER. Battat may transfer the RSUs to family members or one or more trusts or other entities for the benefit of or owned by family members, consistent with applicable securities laws; provided that Battat receives no consideration for the transfer of such RSUs and the transferred RSUs shall continue to be subject to the same terms, conditions, and restrictions as were applicable to such Award immediately before the transfer and such RSUs shall vest according to the same terms as applied to Battat. The RSUs may also be assigned or transferred by will or the laws of descent and distribution.

 

8. NO RIGHT TO CONTINUED EMPLOYMENT. Neither the Plan nor this Agreement shall give Battat the right to continued employment by the Company or shall adversely affect the right of the Company to terminate Battat’s employment with or without cause at any time.

 

9. TAX WITHHOLDING.

 

(a) Regardless of any action the Company or any Subsidiary employing Battat takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other applicable taxes (“Tax Items”) in connection with the Award, Battat hereby acknowledges and agrees that the ultimate liability for all Tax Items legally due by Battat is and remains the responsibility of Battat. Further, if Battat has become subject to tax in more than one jurisdiction between the date of grant and the date of any relevant taxable or tax withholding event, as applicable, Battat acknowledges that the Company or any Subsidiary employing the Battat may be required to withhold or account for Tax Items in more than one jurisdiction.

 

(b) Battat acknowledges and agrees that the Company and any Subsidiary employing Battat: (i) make no representations or undertakings regarding the treatment of any Tax Items in connection with any aspect of the Award, including, but not limited to, the award or vesting of the RSUs, the delivery of the Shares upon vesting and conversion or the subsequent sale of Shares acquired upon vesting and conversion; and (ii) does not commit to structure the terms of the Award or any aspect of the Award to reduce or eliminate Battat’s liability for Tax Items.

 

 
2
 

 

(c) Prior to vesting and conversion of the RSUs, Battat must pay or make adequate arrangements satisfactory to the Company or any Subsidiary employing Battat to satisfy all withholding obligations for Tax Items of the Company or any Subsidiary employing Battat arising from vesting and conversion of the RSUs. In this regard, in lieu of all or any part of a cash payment, Battat may elect to satisfy all or part of the withholding obligations for Tax Items by delivering shares of Common Stock owned by Battat, duly endorsed for transfer, to the Company with a Fair Market Value equal to the amount of the withholding obligations to be satisfied in such manner. The Company or any Subsidiary employing Battat will remit the total amount paid or withheld for Tax Items to the appropriate tax authorities.

 

10. SECTION 409A. This Agreement is intended to comply with Section 409A of the Code and shall be construed and interpreted in a manner that is consistent with the requirements for avoiding additional taxes and penalties under Section 409A of the Code. Notwithstanding the foregoing, the Company makes no representation that the payments and benefits provided hereunder comply with Section 409A of the Code, and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by Battat on account of non-compliance with Section 409A of the Code.

 

11. GOVERNING LAW. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, applied without giving effect to any conflict-of-law principles. The invalidity or unenforceability of any particular provision of this Agreement shall not affect the other provisions hereof, and this Agreement shall be construed in all respects as if such invalid or unenforceable provisions were omitted.

 

12. BINDING EFFECT. This Agreement shall be binding upon and shall inure to the benefit of each of the parties hereto and their respective executors, administrators, personal representatives, legal representatives, heirs, and successors in interest.

 

13. COUNTERPART EXECUTION. This Agreement may be executed in counterparts, each of which shall be deemed an original, but together which shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including .pdf), or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

 

[Signatures appear on the following page.]

 

 
3
 

 

IN WITNESS WHEREOF, the Company and Battat have executed and delivered this Agreement as of the day and year first written above.

  

  ATRION CORPORATION
       
By: /s/ Emile A Battat

 

Name:

Emile A Battat  
  Title: Chairman  
       

 

 

/s/ David A. Battat

 

 

 

David A. Battat

 

  

 
4
 

 

EXHIBIT A

TO

AWARD AGREEMENT

 

1.

Date of Grant: July 1, 2020

 

 

2.

Number of Restricted Stock Units: 1,545.84*

 

 

3.

Form of Settlement: Cash

 

 

4.

Vesting Schedule:

  

 Percentage of Grant

 

Vesting Dates**

20%

 

July 1, 2021

20%

 

July 1, 2022

20%

 

July 1, 2023

20%

 

July 1, 2024

20%

 

July 1, 2025

 

* Subject to adjustment as provided in Paragraph 4 of the Agreement. 

 

** Subject to the provisions of Paragraph 3 of the Agreement.

 

 
5

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
7/1/25
7/1/24
7/1/23
7/1/22
7/1/21
Filed as of:3/1/218-K
Filed on:2/26/218-K
1/1/21
For Period end:12/31/204,  5,  8-K,  SD
12/29/204,  8-K
7/1/204
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/29/24  Atrion Corp.                      10-K       12/31/23   68:4.8M                                   Blueprint/FA
 2/27/23  Atrion Corp.                      10-K       12/31/22   72:5.2M                                   Blueprint/FA
 2/25/22  Atrion Corp.                      10-K       12/31/21   73:5.3M                                   Blueprint/FA
 5/21/21  Atrion Corp.                      S-8         5/21/21    3:82K                                    Toppan Merrill/FA


15 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/09/18  Atrion Corp.                      10-Q        3/31/18   44:2M                                     Blueprint/FA
 3/19/18  Atrion Corp.                      8-K:1,5,9   3/13/18    3:192K                                   Toppan Merrill/FA
11/08/17  Atrion Corp.                      10-Q        9/30/17   41:2M                                     Blueprint/FA
 3/03/17  Atrion Corp.                      8-K:1,2,9   2/28/17    4:755K                                   Toppan Merrill/FA
 5/25/16  Atrion Corp.                      8-K:1,5,9   5/24/16    2:37K                                    Toppan Vite NY Inc./FA
10/31/14  Atrion Corp.                      10-Q       10/27/14   36:1.5M                                   Issuer Direct/FA
 3/12/12  Atrion Corp.                      10-K       12/31/11   39:4.2M                                   Business Wire/FA
 8/04/11  Atrion Corp.                      10-Q        6/30/11   31:1.8M                                   Business Wire/FA
 5/27/11  Atrion Corp.                      8-K:5,9     5/27/11    3:78K                                    Baker Donel… Caldwell/FA
 3/13/09  Atrion Corp.                      10-K       12/31/08    9:1.5M                                   Marketwired/FA
 6/27/07  Atrion Corp.                      S-8         6/27/07    1:145K                                   Baker Donel… Caldwell/FA
 6/27/07  Atrion Corp.                      S-8         6/27/07    1:128K                                   Baker Donel… Caldwell/FA
11/07/06  Atrion Corp.                      10-Q        9/30/06    6:100K                                   Business Wire/FA
 5/12/00  Atrion Corp.                      10-Q        3/31/00    4:28K                                    Toppan Merrill/FA
 1/10/97  Atrion Corp.                      DEFS14A     2/21/97    1:184K                                   Bowne of Atlanta Inc./FA
Top
Filing Submission 0001654954-21-002137   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 4:47:43.1pm ET